Document is current
Any future updates will be listed below
-
Authors
Kero, Tanja
Bär, Sarah
Saraste, Antti
Klén, Riku
Bax, Jeroen J.
Knuuti, Juhani
Maaniitty, Teemu
-
Funding
Funding for this research was provided by:
University of Turku
- License Information
-
More Information
Article History
Received: 10 December 2024
Accepted: 30 March 2025
First Online: 22 April 2025
Declarations
:
: The study complies with the Declaration of Helsinki. The Ethics Committee of the Hospital District of Southwest Finland approved the study protocol and waived the need for written informed consent.
: Dr. Bär received research grants to the institution from Medis Medical Imaging Systems, Bangerter-Rhyner Stiftung (Basel, Switzerland) and Abbott, outside the submitted work. Dr. Knuuti received consultancy fees from GE Healthcare and Synektik and speaker fees from Bayer, Lundbeck, Boehringer-Ingelheim, Pfizer and Siemens, outside of the submitted work. Dr. Saraste received consultancy fees from Astra Zeneca, Novo Nordisk and Pfizer, and speaker fees from Abbott, Astra Zeneca, BMS, Janssen and Pfizer. Dr. Bax received speaker fees from Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
